We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

News

Honorary Doctorates for DZD Board Member Martin Habrĕ de Angelis

The Carl Gustav Carus Faculty of Medicine of TU Dresden has awarded Professor Martin Hrabě de Angelis an honorary doctorate in recognition of his activities for the benefit of university medicine. Already in July of this year, the genetics expert received “the honorary degree of Doctor of Veterinary Medicine” from the Faculty of Veterinary Medicine of Ludwig-Maximilians-Universität.

Feierliche Verleihung der Ehrendoktorwürde der Technischen Universität Dresden an Herrn Prof. Dr. Dr. h.c. Martin Hrabě De Angelis am 22. Oktober 2018 im Festsaal des Rektorats der TU Dresden. Prof. Dr. Michele Solimena (links), Prof. Stefan Bornstein (zweiter von links, Prodekan der Medizinischen Fakultät), Ehrenpromovend Prof. Martin Hrabě de Angelis und Rektor Prof. Hans Müller-Steinhagen. Quelle: André Wirsig für Universitätsklinikum Carl Gustav Carus an der TU Dresden

In Dresden, Professor Hrabě de Angelis received the award "Doctor medicinae honoris causa" in recognition of his outstanding achievements and developments in the field of genomics and diabetes research in Germany and for his achievements in the establishment of German health centers. The honorary doctorate was presented by the Rector of TU Dresden, Professor Hans Müller-Steinhagen, at a ceremony on October 22nd.

In his laudatory address, Professor Stefan Bornstein of the Paul Langerhans Institute (PLID) of Helmholtz Zentrum München at the Carl Gustav Carus University Hospital of TU Dresden said: "With his research in mouse genetics and epigenetics, Professor Hrabě de Angelis has provided important insights for the mechanistic understanding of complex metabolic diseases, including diabetes.”

Professor Heinz Reichmann, dean of the Carl Gustav Carus Faculty of Medicine said in his laudation: “Professor Martin Hrabě de Angelis has shown great commitment and contributed significantly to the further development of university medicine in Dresden. This applies in particular  to the cooperation with high-ranking institutions in the U.S. as well as the development of the  TransCampus research partnership with King's College in London. During the preparation and application for large-scale projects for the Dresden location (EU, Collaborative Research Centres of the German Research Foundation (SFB), development of health centers) he gave important suggestions and assistance, which contributed significantly to the success of the projects. Ultimately, these were also important steps for the excellence initiative of TU Dresden.”

Brief Biography: 
Since 2000, Martin Hrabě de Angelis has been Director of the Institute of Experimental Genetics at Helmholtz Zentrum München. In 2003 he was appointed to the Chair of Experimental Genetics at the Technical University of Munich. Hrabě de Angelis is Director of the European Research Consortium INFRAFRONTIER. In 2001 he founded the German Mouse Clinic (GMC) for the systemic analysis of models for human diseases. He has published more than 500 original papers and is the author of several  reference books. Hrabĕ de Angelis leads research projects on an international level and is one of the founders and a board member of the German Center for Diabetes Research (DZD), which was established in 2009. He is also a member of the National Academy of Sciences, Leopoldina.